Focal and other unusual presentations of facioscapulohumeral muscular dystrophy

Muscle and Nerve

Volumn 46, Issue 3, 2012, Pages 421-425

  Hassan, Anhar ^a   Jones, Lyell K ^a   Milone, Margherita ^a   Kumar, Neeraj ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

4q35; Dyspnea; Facioscapulohumeral dystrophy; Focal; Monomelic

Indexed keywords

ADULT; AGED; ARM WEAKNESS; ARTICLE; ATROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; COHORT ANALYSIS; DATA BASE; DNA DETERMINATION; DYSPNEA; ELECTROMYOGRAM; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; HUMAN; LIMB WEAKNESS; MALE; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; RADICULAR PAIN; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; DYSPNEA; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PHENOTYPE; RETROSPECTIVE STUDIES;

EID: 84865335781     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23358     Document Type: Article

References (38)

1. Padberg GW. Facioscapulohumeral muscular dystrophy: a clinician's experience. In: Upadhaya M, Cooper DN, editors. Facioscapulohumeral muscular dystrophy: clinical medicine and molecular cell biology. Abingdon, UK: Garland Science/BIOS Scientific; 2004. p 41-54.
2. Tawil R, Griggs RC. Facioscapulohumeral muscular dystrophy. In: Rosenberg RN, Prusner SB, Di Mauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease. Boston: Butterworth Heinemann; 1997. p 931-938.
3. Kohler J, Rupilius B, Otto M, Bathke K, Koch MC. Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis. Hum Genet 1996; 98: 485-490.
4. Lemmers RJLF, van der Maarel SM. Facioscapulohumeral dystrophy. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle, WA: University of Washington; 1993-1999 March 8 [updated July 9, 2009].
5. Padberg GW, Lunt PW, Koch MC, Fardeau M. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1991; 1: 231-234.
6. Deidda G, Cacurri S, Piazzo N, Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J Med Genet 1996; 33: 361-365.
7. Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B, and the FSH Consortium. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 1998; 43: 279-282.
8. Richards M, Coppele F, Thomas N, Belayew A, Upadhyaya M. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum Genet 2012; 131: 325-340.
9. Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, et al. Correlation between fragment size at D4F104S1 and age at onset of wheelchair use, with a possible generational effect, accounts for much of the phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 1995; 4: 951-958.
10. Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. Ann Neurol 1996; 39: 744-748.
11. Wang CH, Leung M, Liang WC, Hsieh TJ, Chen TH, Jong YJ. Correlation between muscle involvement, phenotype and D4Z4 fragment size in facioscapulohumeral muscular dystrophy. http://dx.doi.org/10.1016/j.mnd.2011.10.018.
12. Wijmenga C, van Deutekom JCT, Hewitt JE, Padberg GW, van Ommen GJB, Hofker MH, et al. Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions. Genomics 1994; 19: 21-26.
13. Felice KJ, North WA, Moore SA, Mathews KD. FSH dystrophy 4q35 deletion in patients with facial-sparing scapular myopathy. Neurology 2000; 54: 1927-1931.
14. Jardine PE, Upadhaya M, Maynard J, Harper P, Lunt PW. A scapular onset muscular dystrophy without facial involvement: possible allelism with facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1994; 4: 477-482.
15. Krasnianski M, Eger K, Neudecker S, Jakubiczka S, Zierz S. Atypical phenotypes in patients with facioscapulohumeral dystrophy. Arch Neurol 2003; 60: 1421-1425.
16. Reilich R, Schramm N, Schoser B, Schneiderat P, Strigl-Pill N, Muller Hocker J, et al. Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy. J Neurol 2010; 257: 1108-1118.
17. Felice KJ, Moore SA. Unusual presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle Nerve 200; 24: 352-356.
18. van der Kooi AJ, Visser MC, Rosenberg N, van den Berg-Vos R, Wokke JH, Bakker E, et al. Extension of the clinical range of facioscapulohumeral dystrophy: report of six cases. J Neurol Neurosurg Psychiatry 2000; 69: 114-116.
19. Uncini A, Galuzzi G, Di Muzio A, De Angelis MV, Ricci E, Scopetta C, et al. Facioscapulohumeral muscular dystrophypresenting as isolated monomelic lower limb atrophy. Report of two patients with and without 4q35 rearrangement. Neuromuscul Disord 2002; 12: 874-877.
20. Wood-Allum C, Brennan P, Hewitt M, Lowe J, Tyfield I, Wills A. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSH). Neuropathol Appl Neurobiol 2004; 30: 188-191.
21. Kottlors M, Kress W, Meng G, Glocker FX. Facioscapulohumeral muscular dystrophy presenting with isolated axial myopathy and bent spine syndrome. Muscle Nerve 2010; 42: 273-275.
22. Jordan B, Eger K, Koesling S, Zierz S. Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol 2011; 258: 866-873.
23. Bushby KM, Pollitt C, Johnson MA, Rogers MT, Chinnery PF. Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports. Neuromuscul Disord 1998; 8: 574-579.
24. Sugie K, Hayashi YK, Kin T, Goto K, Nishino I, Ueno S. Teaching NeuroImages: hemiatrophy as a clinical presentation in facioscapulohumeral muscular dystrophy. Neurology 2009; 73: e24.
25. Figueroa JJ, Chapin JE. Isolated facial diplegia and very late-onset myopathy in two siblings: atypical presentations of facioscapulohumeral dystrophy. J Neurol 2010; 257: 444-446.
26. Yamanaka G, Goto K, Matsumura T, Funakoshi M, Komori T, Hayashi YK, et al. Tongue atrophy in facioscapulohumeral muscular dystrophy. Neurology 2001; 57: 733-735.
27. Padberg G, Brouwer OF, de Keizer RJ, Dijkman G, Wijmenga C, Grote JJ, et al. On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 1995; 37(suppl 2): S73-S80.
28. Tsuji M, Kinoshita M, Imai Y, Kawamoto M, Kohara N. Facioscapulohumeral muscular dystrophy presenting with hypertrophic cardiomyopathy: a case study.
29. Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald CM. Chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy. Arch Phys Med Rehabil 2008; 89: 320-328.
30. Wohlgemuth M, van der Kooi EL, van Kesteren RG, van der Maarel SM, Padberg GW. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 2004; 63: 176-178.
31. Stübgen JP, Schultz C. Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy. Muscle Nerve 2009; 39: 729-734.
32. Carter GT, Bird TD. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 2005; 64: 401.
33. Kilmer DD, Abresch RT, Aitkens SG, Carter GT, Fowler WM, Johnson ER, et al. Profiles of neuromuscular disease: facioscapulohumeral dystrophy. Am J Phys Med Rehabil 1995; 74(suppl): S131-139.
34. Pastorello E, Cao M, Trevisan CP. Atypical onset in a series of 122 cases with facioscapulohumeral muscular dystrophy. http://dx.doi.org/10.1016/j.bbr.2011.03.031.
35. Vielhaber S, Jakubiczka S, Schroder JM, Sailer M, Feistner H, Heinze H, et al. Facioscapulohumeral muscular dystrophy with EcoRI/BInI fragment size of more than 32 kb. Muscle Nerve 2002; 25: 540-548.
36. Butz M, Koch MC, Muller-Felber W, Lemmers RJ, van der Maarel SM, Schreiber H. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers. J Neurol 2003; 250: 932-937.
37. Arahata K, Ishihara T, Fukunaga H, Orimo S, Lee JH, Goto K, Nonaka I. Inflammatory response in facioscapulohumeral muscular dystrophy (FHSD): immunocytochemical and genetic analyses. Muscle Nerve 1995; 2(suppl): S56-66.
38. + T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol 2010; 31: 155-166.